What is Valeant Pharmaceuticals called now?

What is Valeant Pharmaceuticals called now?

Valeant Pharmaceuticals International Inc. plans to change its name to Bausch Health Cos., as management takes another step toward remaking the company and distancing it from past controversies.

Where is Valeant Pharmaceuticals located?

Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada.

What drugs does Valeant make?

It wasn’t just lifesaving drugs such as Syprine and Cuprimine. Investors celebrated a drug called Jublia, which Valeant had developed itself—to treat toenail fungus.

Is Valeant Pharmaceuticals still in business?

LAVAL, Quebec, July 13, 2018 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company” or “we”) today announced the Company’s name change from Valeant Pharmaceuticals International, Inc. to Bausch Health Companies Inc. is complete.

Who owns Syprine?

Bausch acquired Syprine as part of its acquisition of Aton Pharmaceuticals in 2010. Syprine’s cost rose to $21,267 in four years, the documentary maintained.

Who are the biggest short sellers?

Here are the biggest short squeezes in the stock market, including Virgin Galactic and AMC Networks

Company Ticker % short
Workhorse Group Inc. WKHS 40.32%
Lemonade Inc. LMND 29.41%
AMC Networks Inc. Class A AMCX 25.58%
Bed Bath & Beyond Inc. BBBY 32.25%

What happened to Mike Pearson Valeant?

Since the fraudulent marketing scandal came to light in 2015, Valeant cut ties with Philidor—which later closed shop—but couldn’t stop a sharp decline in its share price. Its former CEO J. Michael Pearson stepped down in 2016, giving way to current helmsman Joseph Papa.